Moxifloxacin eye drop having both bionic function and targeting function and preparation method thereof

A technology of moxifloxacin and moxifloxacin hydrochloride, which is applied in the field of moxifloxacin eye drops and its preparation, can solve problems such as increased difficulty, achieve targeted absorption, increase cell uptake, and improve bioavailability Effect

Inactive Publication Date: 2016-12-21
SHANGHAI HAOHAI BIOLOGICAL TECH
View PDF5 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At the same time, due to the renewal effect of tears, the medicine can only stay in the eye for 1 to 2 minutes

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Moxifloxacin eye drop having both bionic function and targeting function and preparation method thereof
  • Moxifloxacin eye drop having both bionic function and targeting function and preparation method thereof
  • Moxifloxacin eye drop having both bionic function and targeting function and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0029] Example 1: Preparation of moxifloxacin eye drops with both tear bionic and corneal targeting functions.

[0030] formula:

[0031]

[0032]

[0033] Preparation:

[0034] (1) Weigh 5.0 g of moxifloxacin hydrochloride, add it to 400 ml of distilled water, heat to 50-80 ° C, stir to dissolve it, and obtain solution A;

[0035] (2) Add 4.0 g of sodium hyaluronate to solution A prepared in step (1), heat to 50-80°C, stir to dissolve it, and obtain solution B;

[0036] (3) Weigh 3.0 g of xanthan gum and 6.0 g of sodium chloride, add them to 400 ml of distilled water, stir to make them fully swell, and pass through 5 μm and 1 μm secondary filter membranes to obtain solution C;

[0037] (4) Slowly add the solution B prepared in the step (2) to the solution C prepared in the step (3), adjust the pH to 7.0 with a borate buffer solution, replenish water to 1000ml, and obtain the solution D;

[0038] (5) The solution D prepared in the step (4) was sterilized by high-press...

Embodiment 2

[0039] Example 2: Preparation of moxifloxacin eye drops with both tear bionic and corneal targeting functions.

[0040] formula:

[0041]

[0042] Preparation:

[0043] (1) Weigh 6.0 g of moxifloxacin hydrochloride, add it to 400 ml of distilled water, heat to 50-80 ° C, stir to dissolve it, and obtain solution A;

[0044] (2) Add 1.0 g of sodium hyaluronate to solution A prepared in step (1), heat to 50-80° C., stir to dissolve it, and obtain solution B;

[0045] (3) Weigh 5.0 g of xanthan gum and 8.0 g of sodium chloride, add them to 400 ml of distilled water, stir to make them fully swell, and pass through 5 μm and 1 μm secondary filter membranes to obtain solution C;

[0046] (4) Slowly add the solution B prepared in the step (2) to the solution C prepared in the step (3), adjust the pH to 6.0 with a borate buffer solution, replenish water to 1000ml, and obtain the solution D;

[0047] (5) The solution D prepared in the step (4) was sterilized by high-pressure steam at...

Embodiment 3

[0048] Example 3: Preparation of moxifloxacin eye drops with both tear bionic and corneal targeting functions.

[0049] formula:

[0050]

[0051] Preparation:

[0052] (1) Weigh 5.45g of moxifloxacin hydrochloride, add it to 400ml of distilled water, heat to 50-80°C, stir to dissolve it, and obtain solution A;

[0053] (2) Add 2.0 g of sodium hyaluronate to solution A prepared in step (1), heat to 50-80°C, stir to dissolve, and obtain solution B;

[0054] (3) Weigh 4.0 g of xanthan gum and 7.0 g of sodium chloride, add them to 400 ml of distilled water, stir to make them fully swell, and pass through 5 μm and 1 μm secondary filter membranes to obtain solution C;

[0055] (4) Slowly add the solution B prepared in the step (2) to the solution C prepared in the step (3), adjust the pH to 8.0 with a borate buffer solution, replenish water to 1000ml, and obtain the solution D;

[0056] (5) The solution D prepared in the step (4) was sterilized by high-pressure steam at 121°C...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Molecular weightaaaaaaaaaa
Login to view more

Abstract

The invention discloses a moxifloxacin eye drop having both a bionic function and a targeting function and a preparation method of the moxifloxacin eye drop. Specifically, the moxifloxacin eye drop comprises the following components according to mass concentration: 5-6g/L of moxifloxacin hydrochloride, 3-5g/L of xanthan gum, 1-4g/L of sodium hyaluronate, 6-8g/L of an isoosmotic adjusting agent, and the balance of distilled water; the pH value is regulated through a pH regulator to 6.0-8.0. A xanthan gum/sodium hyaluronate gel system is creatively applied compositely to achieve both the bionic function of tears and the targeting function of a cornea; the xanthan gum has the bionic rheological property similar to that of the tear, so that higher viscosity is achieved when the shearing force is low, and the xanthan gum is evenly coated on the surface of an eyeball when the shearing force is high; the sodium hyaluronate acts on a receptor CD44 of a corneal cell, so that the cell intake is increased, and the targeting absorption is achieved. Compared with a common moxifloxacin eye drop, the moxifloxacin eye drop having both the bionic function and the targeting function has the characteristics of compatibility with the tear, no foreign-matter irritation, long residence time, higher bioavailability and the like.

Description

technical field [0001] The invention belongs to the technical field of medicine, and relates to a moxifloxacin eye drop with tear bionic and corneal targeting functions and a preparation method thereof. Background technique [0002] The ocular drug delivery system is a drug delivery system with local therapeutic characteristics. It is mainly used clinically for antibacterial, anti-inflammatory, mydriasis, anesthesia, treatment of glaucoma, and reduction of intraocular pressure. At present, ophthalmic drugs are mainly divided into eye drops, eye oils, eye ointment, subconjunctival injection and intravitreal injection. Topical instillation of drugs is the preferred way of ocular administration, but due to the innate protection of the eye against foreign substances, the bioavailability of the drug is low, and only 5% of the drug can be absorbed through the cornea . [0003] The main barriers for ocular instillation come from the three major barriers in the anterior segment: t...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K9/08A61K47/36A61K31/4709A61P31/04A61P27/02
CPCA61K9/08A61K9/0048A61K31/4709A61K47/36
Inventor 张真真廉云飞张军东吴剑英
Owner SHANGHAI HAOHAI BIOLOGICAL TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap